Navigation Links
Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society

afety. HUMIRA is a registered trademark of Abbott Laboratories.

The data from this clinical trial support the study hypothesis that rHuPH20 increases the relative bioavailability of the SC injected HUMIRA:

    -- For the primary endpoint of area under the curve (AUC) for adalimumab

       plasma concentration, the AUC over the 14 days following administration

       was higher when the HUMIRA was co-injected with rHuPH20 compared to the

       HUMIRA injection without rHuPH20 for 100% (15/15) of the patients in

       the study.


    -- The modeled population PK analysis estimated a 59% maximal increase in

       the relative SC bioavailability of adalimumab at steady state if

       co-injected with rHuPH20; thus, the reported reference 64% SC absolute

       bioavailability HUMIRA injected alone was estimated to increase to 100%

       when co-injected with rHuPH20, achieving essentially complete

       absorption.


    -- The modeled PK analysis estimated that a high dose of rHuPH20 (at least

       6,400 U) was required to assure the maximal rHuPH20 effect.


    -- Injection of rHuPH20 with HUMIRA was well tolerated at all rHuPH20 dose

       levels, without dose-limiting toxicity, premature withdrawals, or

       serious adverse events.  Of the total of five adverse events reported

       in this study, two were assessed as having no association with either

       study drug (basal cell carcinoma and urinary tract infection).  The

       remaining three events consisted of mild injection site erythema

       (redness) that occurred on the day of the co-injection and resolved

       within one or two days.

As a spreading agent, hyaluronidase has traditionally been used to accelerate the delivery of drugs and fluids, including local anesthetics, other co-injected drugs, and contrast agents, and for subcutaneous fluid replacement. Although a large body of clinical experience supports the benefits and safety of using
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
7. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
10. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
(Date:7/24/2014)... July 24, 2014  Lazarus Effect, a medical ... interventional devices to facilitate removal of blood clots, ... Trademark Office has issued a new patent (U.S. ... company,s Lazarus Cover TM and ReCover TM ... is a single-component stent-retriever (stentriever) with an integrated, ...
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Monitoring Market by Product, Component, Application and Geography - ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... expected to witness a moderate growth as the markets ... have almost reached the saturation levels. The demand is ...
(Date:7/24/2014)... India , July 24, 2014 Consolidated ... Business Highlights   , India Business ... grew by 9.33% to Rs. 4,886.70 Mn Rest of ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... Mn , Glenmark Pharmaceuticals Limited, the research-led ...
Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4
... Challenges Explorations to support bold, ... diseases, SEATTLE, March 3 The Bill & Melinda ... accept grant,proposals for the first funding round of Grand Challenges ... globe pursue,ideas that have never before been tested for solving ...
... Research Management,Organization (RMO), has contracted with Systems Medicine ... (CTI), to provide,research and site management services for ... myxoid liposarcoma with a (12;16),translocation. The study is ... experimental drug product, brostallicin. The trial will also ...
Cached Medicine Technology:Gates Foundation Seeks Proposals for Innovative Global Health Research 2Gates Foundation Seeks Proposals for Innovative Global Health Research 3Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial 2Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial 3
(Date:7/24/2014)... July 24, 2014 The South American air ... million in 2014 and is expected to register a CAGR ... spends mainly on tackling internal security issues like drug trafficking. ... 75% share in the air and missile defense radar market. ... promising future in the market for radar systems in terms ...
(Date:7/24/2014)... The National Resident Matching Program (NRMP) ... new version of its smartphone app, The MATCH Program ... participating in NRMP’s Main Residency Match® and Specialties Matching ... program information during the interview process and develop program ... order lists. Rank order lists are used by ...
(Date:7/24/2014)... Indianapolis* VxP Pharma Services announced today ... include process development and commercial manufacturing for ... offered by VxP now include:, ...     Sterile Liquids and Sterile Powders , ...     Transdermal Patches ,     Animal Health ...
(Date:7/24/2014)... July 24, 2014 Becker's Hospital Review ... Hospitals and Health Systems With Great Oncology Programs." Organizations ... terms of quality patient care, cancer outcomes and research. ... for inclusion based on rankings and awards they have ... awards were considered as part of the criteria for ...
(Date:7/24/2014)... Dr. Kwame Bawuah Edusei, a diplomat, entrepreneur, medical ... to the youth to persevere in their endeavors to ... the youth to stay away from social vices and ... will afford you the opportunity of acquiring life surviving ... in your career path.” Professionals in the fields of ...
Breaking Medicine News(10 mins):Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 3Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 4Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 5Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3Health News:VxP Pharma Expands Commercial Service Offering 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 3Health News:100 Hospitals, Health Systems With Great Oncology Programs 4Health News:Youth and Professionals Interact at Washington Metro Area Career Workshop Hosted by the Edusei Foundation 2
... critical levels compelled the Iranian Government to declare two ... country will remain closed on// 7 and 8 December ... Tehran have already been closed down by the Government, ... problems have been advised to remain indoors. ...
... persistent pain may be increased by an inflamed injury, according ... even after it has disappeared//. Several million Canadians are reported ... has published the study. The NR2B proteins in mice are ... to imprint upon the brain a painful response even when ...
... treatment can be given to eligible patients inclusive ... stage III colon cancer, according to the Journal ... study. The survival rates are reportedly higher with ... received chemotherapy after surgery to treat their advanced ...
... of the deadly bird flu, official reports from China has ... to be infected with the disease//. The victim hails from ... and pneumonia since November 23. ,A test done ... H5N1 infection and has a positive history of exposure to ...
... Two Chinese manufacturers who were making and selling inferior ... of several children after being fed with this fake ... estimates, up to 200 babies after being fed the ... doctors diagnosed the condition as "big head disease", where ...
... mechanism by which Hepatitis C could cause liver cancers is ... from the University of Texas have now discovered a biochemical ... between liver cancer and Hepatitis C. The link or association ... human papilloma virus (HPV), cervical cancer and genital warts. ...
Cached Medicine News:Health News:Chemotherapy Treatment Can Be Given To The Elderly also 2Health News:Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia 2Health News:Link Between Hepatitis C And Liver Cancer Unraveled By Scientists 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled bevel down. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: